The toxicity of neostigmine against Aedes aegypti larvae by Kong, Sau, Mun
THE TOXICITY OF NEOSTIGMINE AGAINST 
AEDES AEGYPTI LARVAE 
by 
KONGSAUMUN 
Dissertation submitted in partial fulfillment of the 




This is to certify that the dissertation entitled 
"The toxicity of neostigmine against Aedes aegypti larvae" 
is a bonafide record of research work done by 
Miss Kong Sau Mun 
Signature of supervisor: 
Name and address of supervisor: Mr. l ahangir Kamaldin 
Lecturer 
School of Health Sciences 
Universiti Sains Malaysia 
Health Campus 
16150 Kubang Kerian, Kelantan . 
Date: 7 May 2006 
Signature of co-supervisor: ... ~~~. l~ .~~ 
Name and address of co-supervisor: Dr. Shyamoli Mustafa 
Lecturer 
School of Health Sciences 
Universiti Sains Malaysia 
Health Campus 
16150 Kubang Kerian, Kelantan. 
Date: 7 May 2006 
ACKNOWLEDGEMENTS 
First of all, I would like to express my deepest gratitude to my supervisor, Mr. lahangir 
Kamaldin for the research title, method and funding for the conduct of my final year 
research. Thanks for the ceaseless effort in his guidance and advice to make my project 
come to success. Besides that, my knowledge on mosquito has been widen greatly due 
to him . 
Special appreciation to my co-supervIsor, Dr. Shyamoli Mustafa for critical and 
thorough reading of this thesis. 
I would also like to thank Environmental Laboratory' s Supervisor, Kak luskasmini for 
her help. Thanks for teaching me and always help me whenever I needed it. I am also 
grateful to Environmental Lab's research assistants, Kak Husna and Kak Asima for their 
assistance. 
I would also like to say thank you to my course mates that also did their research in 
Environmental Lab namely Siew Mun, luzaila and Arba' iyah. Without them and their 
cooperation, it will be a tough task for me to finish my research on time. 
Last but not least, I would also like to thank my friends that keep giving me the support 
and valuable comments. Very special thanks to Arthur, May Wan, Fong Wei, Gim 
Cheong, Yu Cheng and Yung Shin that always be my side. 
11 
In addition, thanks to my family who always there to gIve me support and 
encouragement even though I could not come back home at holidays due to the project 
works. 
Lastly, thank you again to all that have helped to make this thesis a success. 
III 
CONTENTS 
Title page .................. ...... . ........ .. ....... . . • .... 1 
Acknowledgement . . . .... . . ... .. . . . . . . .. . . . . ... . . . ... .. . .. . ... . . . .. .. . . ... . .. . ..... . .. .. .... .... 11 
Contents .. . ...... . .......... . .. . . . . . . . ... . . . .. ...... ....... .. .. ... .... .. . ...... . .. ... ..... ... .... IV 
List of tables and figures ...... ...... .. .... .. . ......... . .... .. .. . .. ..... ... ....... . .............. vi 
Abstract.. .... ... .. . ................. ....... ..... . ......................... ......... ...... .... Vlll 
Abstrak ..... ....... . .... . ..... . ...... .. . . ......... . .. .. ... ... . .... . ..... ... . .. . .. .... .......... .. .ix 
1. 0 Introduction .. . .. . .. . . .. . .. .. . .. . .. . .. . . .. .. . .. . . .. .. . .. . . .. .. .. .. . .. . .. .. . . .. .. . .. . .1 
2.0 Literature review ............... .. . . .. ... ... .. .. ..... . ........... .......................... .4 
2.1 Dengue ..................... .. ...... .. .. .... .... .... .............. ... ... . .4 
..... 8 2.2 Aedes aegypti mosquitoes ........ .. .......... ... .. ... ... ... .. ......... . 
2.3 Geographic di stribution .......... .... ............. . . ... ........ .. 9 
2.4 Life cycle of Ae. Aegypti ............. . .. ..... .. ... . . ..... ... ... .. ... ... 9 
2.4. I Adult. ... ... . ......... . ....... . .................. .... .. . . . 12 
2.4.2 Egg .... . . . . .. .. .. . .... . ... . .. ..... ... ........ . ........ . ........ 14 
2.4.3 Larva. 
2.4.4 Pupa. 
2.5 The nervous system of insects 
2.6 Insecticide .......... . ... . ........ .. .. .. .... . 
2.6.1 Temephos ......... ....... .. . 
2.6.2 Resistance ..... . .. ... .. .. .. .. ... .. 
. .... ......... .. 15 
.. ........ .. . . .. 16 
.... .. .. .. .... ... ... 16 
. . . ..... .. ........ 20 
.. .. . ...... ..... 21 
2.7 Cholinergic synapse ..... .. ... .. .. ... ................ . 
..2 1 
. ..... 22 
2.8 Neostigmine . . . .. .. 22 
3.0 Materials and methods .. . ... . ... .... . .. .... . ... . ... . . .. .. . . 26 
IV 
3.1 Materials ....................... . . ................ .. ...... ..... ....... . ........ 26 
3.1.1 MosquitoLarvae .. .. . . . . .. . .. ... . ... .... ... ... ... . . . . ...... 26 
3.1.2 Neostigmine ..... . .. . . . .. . .. .. .. . .. . . ..... .. . . . .. . .. .. ...... 26 
3.1.3 Abate ........ . ........ . .. ...... . . .... .... . ....... .. ........... 27 
3.2 Methods .... . .. ........................... . .. . . . . .. . ...... . . .. . ..... . . ....... 27 
3.2.1 Larvicidal Bioasssay ...... .. ... . ........ ..... .............. 27 
3.2.2 Statistical Analysis ...... . . . . . .. .... . . . . . .. . . . . . . ... . ...... 28 
3.3 Experiment overview ........ . ........ . . . ...... . ... . ....... . . .............. 29 
4.0 Result . .. ......... . . ..... . . .. . .. . .... ... . . .. . . .. .. . . ... ... . . .. ..... .. .. . . . ... . .. ........... 30 
5.0 Discussions............ . ..... .. . . ..... .. .. . . . .. .. .. . ... . . .. ..... . .. ..................... 38 
6.0 Conclusion ........ . . ...... . . . ... .... .. ... .. . .. . . . ... .. . .... ........ . ........ . ... . .... . . .42 
7.0 References ..... ... .. . ... ... . . .. ... . ... . ...... . . ....... .. ..... . .. . . .. . .... .... . . .... .43 
Appendix ........ . . ..... .... ........ .. ... . ........ 53 
v 
LIST OF TABLES AND FIGURES 
TABLES 
Table 2.1 Properties of neostigmine methyl sulphate ............... . . ...... ... . . .. ... 25 
Table 3.1 Volume of Neostigmine Injection B.P. for the respective treatment 
dosages ............................. . .27 
Table 4.1 The result ofIndependent T test. . ............. . . . ... . . .. ....... . . .. .. .. ..... 37 
FIGURES 
Figure 1.1 Distribution and number of pesticide-related illnesses by insecticide 
chemical class in year 1998 to 1999 in United States ...... ............ .. .. 3 
Figure 2.1 The distribution of Aedes and dengue fever in the year of 2003 .5 
Figure 2.2 Reported Cases ofDFIDHF in Selected Countries in SEA Region from 
1985 to 2004* ..... ... ' " . ............... . . . .............. . . . .... .... . . ... .... 7 
Figure 2.3 The life cycle of Aedes aegypti mosquito .......... . ........ . . .. . . . . . .11 
Figure 2.4 Diagram of the reflex mechanism of an insect. .. .... 19 
Figure 2.5 Action of neostigmine at synaptic cleft ....... .. ............. . .. .. . .. . . ... 24 
Figure 4.1 The graph showing percentage of cumulative mortality of larvae in 
control group and 12.5 ppm neostigmine treated group .. .. .. ... 32 
Figure 4.2 The graph showing percentage of cumulative mortality of larvae in 
control group and study group treated with 25 ppm of neostigmine 
. ..... .. .... .. .. .... . .... ... ...... .... ... , .... .............. ..... ... ... .... ...... ... ... ..... ...... .. . .. 33 
Figure 4.3 The graph showing percentage of cumulative mortality in larvae of 
control group and the 50 ppm neostigmine treated group ...... .... 34 
VI 
Figure 4.4 The graph showing percentage of cumulative mortality of larvae in 
control group and in 100 ppm of neostigmine treated group ...... . .. 35 
Figure 4.5 The graph showing percentage of cumulative mortality of larvae in 
control group and (benchmark) temephos treated group ........... . .. 36 
VII 
ABSTRACT 
The yellow fever, dengue fever and chikungunya are the important mosquito-borne 
disease to human in the world. Aedes mosquitoes have been widely studied for its role 
as the vector for these diseases. Various larvicides have been introduced to control the 
mosquito population. Among all , temephos is the most popular and widely used . The 
frequent use of temephos has resulted in the development of resistance in field 
populations of Aedes mosquitoes in Malaysia. Thus, this study was carried out to 
explore the potency of utilizing Neostigmine Inj ection B.P. 2. 5 mg (neostigmine) as an 
alternative larvicide subsequently delaying the development of resistance of mosquitoes 
against temephos. The potency was evaluated by assessing the toxicity of neostigmine 
against larvae of Ae. aegypti. Neostigmine is a drug used in the treatment for 
myasthenia gravis due to its effects as an anticholinesterase. The drug was chosen 
because of its mode of action, which is similar to organophosphate larvicide. In the 
study, four different dosages of neostigmine were evaluated, i.e. 12.5, 25, 50 and 100 
ppm against the late third to early fourth instar larvae of Ae. aegypti using the modified 
WHO (1981) method . Temephos was included in the test regime as the benchmark and 
distilled water only as the control. The tests were conducted in fi ve replicates for 
twenty-one days. The percentage of cumulative mortality of larvae was calculated and 
analyzed with Independent T test. The results showed 100 ppm of neostigmine has the 
highest percentage of mortality (99.2 %), followed by 50 (97.6 %), 12. 5 (968 %) and 
25 (94.4 %) ppm. The increase of mortality was significant (P < 0.05) for neostigmine 
at 100 ppm dosage compare to control. For treatment of 50 ppm of neostigmine, the 
increase of mortality was only significant at P < 0.10. However, when compared to 
temephos, the percentage of mortality generated by 100 ppm neostigmine was 
significantly (P < 0.05) lower. 
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Ketoksikan Neostigmine Terhadap Larva Aedes aegypti 
ABSTRAK 
Demam kuning, demam denggi dan chikungllnya merupakan antara penyakit bawaan 
nyamuk yang penting bagi manusia. Nyamuk Aedes telah pun luas dikaji dalam 
peranannya sebagai vektor. Pelbagai jenis racun larva telah diperkenalkan bagi 
mengawal populasi nyamuk dan di antaranya temephos merupakan racun yang paling 
luas digunakan. Kekerapan penggunaan temephos yang tinggi telah menyebabkan 
kerintangan terhadap temephos di kalangan populasi nyamuk Aedes di Malaysia. Oleh 
itu, kajian ini telah dijalankan bagi menguji potensi ubat Neostigmine Injection B .P. 2.5 
mg (neostigmine) sebagai alternatif kepada racun larva dan seterusnya memperlahankan 
kerintangan larva terhadap temephos. Potensi ubat neostigmine dikaj i dengan 
memerhatikan ketoksikannya terhadap larva Ae. aegypti. Ubat neostigmine mempunyai 
kesan sebagai anticholinesterase dan digunakan untuk merawat penyakit seperti 
myasthenia gravis. Ubat ini dipilih kerana ia mempunyai tindakan yang mimik racun 
serangga kumpulan organofosfat. Dalam kajian ini, empat kepekatan neostigmine yang 
berlainan telah digunakan, iaitu 12.5, 25, 50 dan 100 ppm terhadap larva peringkat 
lewat instar ketiga dan peringkat awal instar keempat dengan menggunakan kaedah 
WHO (1981) yang telah diubahsuai. Temephos turut dirangkumi dalam set ujian sebagai 
penanda aras manakala air suling digunakan sebagai kawalan. Kajian adalah dijalankan 
dalam lima replikasi bagi dua puluh satu hari . Peratusan kematian terkumpul larva 
dikira dan dianalisa dengan menggunakan ujian Independent T. Keputusan kajian 
menunjukkan neostigmine pada kepekatan 100 ppm menunjukkan peratusan kematian 
larva yang paling tinggi (99.2 %) (ni diikuti dengan kepekatan 50 (976 %), 12.5 (96.8 
%) dan akhirnya 25 (94.4 %) ppm. Peningkatan peratusan kematian adalah signifikan (P 
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< 0.05) bagi kepekatan neostigmine pada 100 ppm berbanding dengan kawalan. 
Manakala bagi neostigmine 50 ppm, peningkatan peratusan kematian hanya signifikan 
pada P < 0.10. Walau bagaimanapun, apabila perbandingan dibuat dengan temephos, 




World Health Organization (WHO) classified the virus for dengue fever as the most 
important arbovirus to human in the world. Aedes aegyp fi has been found to transmit the 
dengue viruses. It is estimated that each year, a total of 50 million infections of dengue 
virus occur with 500,000 cases of dengue hemorrhagic fever and 12,000 deaths 
(Academy of Medicine Malaysia, 2003). The factors that contribute to dengue outbreaks 
are increase of uncontrolled demographic, poor urban planning, reduced 
epidemiological surveillance and progressive resistance of the vector mosquito to 
insecticides (Carolina et al., 2004). Besides the transmission of dengue viruses, Aedes 
aegypli is also the vector of the viruses of yellow fever and chikungunya. 
Integrated Mosquito Control program is carried out in countries facing the treat in order 
to suppress mosquito populations. Mosquito control program targets the larval stage of 
Ae. aegypti to ensure effective protection to human populat ion. According to 
Dharmagadda el al., (2005), it is much easier to control the mosquito population in the 
larval stage and this can reduce the overall application of adulticides. 
There are various examples of larvicides, like peppermint oil (Ansari el al., 2000), 
Bacillus Ihuringiensis israelensis (bti), temephos, methoprene and monomolecular film s 
(EPA, 2002). Temophos is a popular larvicide. Temephos is an organophosphate 
pesticide that affects the nervous system by reducing the ability of cholinesterase to 
function properly in regulating acetylcholine (Lee et aI. , 1997). If acetylcholine is not 
properly controlled by cholinesterase, the nerve impulses or neurons remain active 
longer than they should, which continuously stimulates the nerves and muscles. 
Subsequently causing symptoms such as weakness or paralysis of the muscles. Due to 
the frequent use of temephos, it has resulted in the development of resistance in field 
populations of Aedes mosquitoes in Malaysia (Seleena el aI., 200 1). Besides the 
resistance, temephos and other organophosphate could cause contamination of water 
and injury to human or animals that were not the targets of the pesticide. Figure 1.1 
shows the distribution and number of organophosphate-related illnesses in year 1998 to 
1999 in United States (NIOSH, 2004). 
Neostigmine is an anticholinesterase drug approved by Ministry of Health, Malaysia for 
use in treatment of myasthenia gravis, postoperative distension or urinary retention and 
antidote for tubocurarine (Delmar, 2002). The effect of neostigmine on neural system is 
similar to organophosphate insecticides, such as temephos, that is as an 
acetylcholinesterase inhibitor (James e/ aI. , 1996, Delmar, 2002). Thus, it is believed 
that neostigmine could also act as a larvicide. 
In addition, ri sk of the health hazard from neostigmine could be relatively lower than 
temephos based on the use of neostigmine as drug for human compared to temephos. 
Thus, the use of neostigmine as larvicide may seem to provide a safer option compared 
to temephos. 
The objective of this research was to explore the potency of neostigmine as larvicide by 
evaluating the toxicity of neostigmine against larvae of Ae. aegypli. If the result is 
positive, then it indicates the potency of neostigmine to be used as an alternative to 





















Figure 1. I : Distribution and number of pesticide-related illnesses by insecticide 
chemical class in year 1998 to 1999 in United States 
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2.0 LITERATURE REVIEW 
2.1 Dengue 
WHO reported dengue as the most common mosquito-borne viral disease of humans. In 
recent years, it became a major international health concern, as 2.5 billion people live in 
areas where dengue viruses can be transmitted globally. Dengue fever (OF) has become 
an important public health problem as the number of reported cases continues to 
increase, especially the severe forms of the disease, dengue haemorrhagic fever (DHF) 
and dengue shock syndrome (DSS), or with unusual manifestations such as central 
nervous system involvement (Wej et ai., 2004). 
The geographical spread of both the mosquito vectors and the viruses has led to the 
global resurgence of epidemic DF and emergence of DHF in the past 25 years with the 
development of hyperendemicity in many urban areas in the tropics. The geographical 
spread, incidence and severity of DF and DHF are increasing in the America, South-
East Asia, the Eastern Mediterranean and the Western Pacific. It is estimated that each 
year 50 million infections occur, with 500,000 cases of DHF and at least 12,000 deaths 
(Academy of Medicine Malaysia, 2003). Figure 2.1 shows distribution of Aedes and 
dengue fever in the year of 2003. 
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World Distribution of Dengue II 2003 
\ 
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o Areas infested witll Aedes aegjipLi 
Areas 'i'l ilh liedes aegypti E1r d der gue epiden'lic activity 
Figure 2. 1. The distribution of Aedes and dengue fever in the year of2003 (CDC, 2006) 
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The earliest report of a dengue epidemic in Peninsular Malaysia was from Singapore 
and it was in 1901. In Malaysia, the presence of dengue fever was first reported in 1902 
in Penang Island (Rebecca, 1992). The first major outbreak of DHF in Malaysia 
occurred in the year 1973 and dengue type 3 was considered to be the main causal type 
(Wallace et aI., 1980). 
In the year 2003, about 140,000 cases ofDF and DHF were reported in the South-East-
Asian region (Figure 2.2), while the case fatality rate for the same year is 0.85 % (WHO, 
2004). In Malaysia, 16,368 cases were reported in the year 2001 and 22 % of these were 
children aged 14 years and below. Similarly, the case fatality rate for DHF is high, 
ranging from 5 % to 6 % per annum for both children and adults. In that particular year, 
there were 50 cases of death from DF and the incidence rate was 68.79 per 100000 
(Academy of Medicine Malaysia, 2003). 
According to Carolina et aI., (2004), the factors accounting for dengue outbreaks are 
increase of uncontrolled demographic, poor urban planning, reduced epidemiological 
surveillance and progressive resistance of the vector mosquito to several insecticides 
produced by the chemical industry. 
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2.2 Aedes aegypti mosquitoes 
Mosquitoes are the most prominent of the numerous speCIes of blood-sucking 
arthropods that irritate man and other warm-blooded animals (Maurice and Robert, 
1969). They are also the vectors that are responsible for spreading serious human 
diseases like malaria, Japanese encephalitis, West Nile virus, yellow fever, dengue and 
filariasis (Veena et al., 2005, Deborah et aI., 2004). Mosquito-borne diseases have 
emerged or re-emerged as significant human health problems due to a number of factors, 
which include lack of progress in vaccine development, emergence of drug resistance in 
pathogens and insecticide resistance in mosquitoes, and the decline in socioeconomic 
conditions in many disease endemic countries that limits disease monitoring and 
mosquito control efforts (David et aI., 2004). 
The mosquito species, Aedes aegypti, is the primary, worldwide arthropod vector of the 
viruses of yellow fever, dengue viruses and chikungunya (Maurice and Robert, 1969, 
Nongkran et aI., 2005, David et aI., 2004). 
The taxonomy of the mosquito is as stated below: 
• Kingdom: Animalia 
• Phylum: Arthropoda 
• Class: Insecta 
• Order: Diptera 
• Family: Culicidae 
0 Genus: Aedes 
0 Species: Aedes aegypti 
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According to David et aI., (2004), this species of mosquito is considered as the most 
tractable mosquito species for laboratory culture, and has been used for detailed 
laboratory investigations of mosquito biology including morphology, physiology, 
genetics, vector competence, and recently, molecular evolution applications. 
2.3 Geographic distribution 
Canyon (2001) in his review article mentioned that while the latitudinal limits of Ae. 
aegypti are 45° North and 40° South of the equator, Ae. aegypti's distribution is more 
closely correlated with the 10°C isotherms, and is found throughout most tropical to 
subtropical regions of the world (Womack, 1993). Canyon also pointed out that the 
estimation of Ae. aegypti distribution and density are affected by the life-limiting factors 
of latitude, altitude, temperature, rainfall, humidity, season, habitat and dispersal. 
Ae. aegypti is highly susceptible to temperature variations and its survival is poor in hot 
and dry climates (Womack, 1993). According to Maurice and Robert (1969), it soon 
dies in the open air at a temperature of 7 to 8 °C, succumbing in a few seconds when 
exposed to a temperature of 0 °C. It also dies quickly at 37 °C (Maurice and Robert, 
1969). 
2.4 Life cycle of Ae. aegypti 
Metamorphosis is the series of changes in the organism to achieve the size and 
development of the parent, in which the young insect undergoes greater or less change 
in size, form and structure. Among all types of metamorphosis, Ae. aegypti undergoes 
complete metamorphosis or holometalobous development (Figure 2.3). 
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During the intervening metamorphosis, this insect undergoes considerable structural and 
functional remodeling. The larval stage is an active, feeding and wormlike. Wing 
development is suppressed. The larva increases in size through successive instars, and at 
the end of the larval period, it passes into pupal stage, in which a radical transformation 
takes place (Robert et ai., 1991). 
Many internal larval tissues are destroyed by autolysis and phagocytosis, and adult 
structures develop from imaginal cells that are set aside during embryonic and larval life. 
At pupal stage, the internal remodeling occurs within an epidermal body wall that 
changes from a relatively simple segmented tube to the geometrically complex triad of 
head, thorax, and abdomen characteristic of adult insects (Gema et ai., 2003). 
According to James et ai., (2005), the transformation of the immature insect into 
reproducible adult is under a cascade of transcriptional events that occur in response to 
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Ae. aegypti is small in comparison to others. It is usually between three to four 
millimeters in length, discounting leg length. The body is composed of a well-defined 
head, thorax and abdomen. It is marked with silvery-white or yellowish white bands and 
stripes on a nearly black background (Roland et ai., 1998). It has a "lyrelike" pattern 
dorsally on its thorax formed by two outer-curved yellowish-white lines and two 
median parallel lines. The legs are seen as banded, and the last segment of the hind leg 
is entirely white. Its head is covered with broad flat scales with a single row of upright 
forked scales (Maurice and Robert, 1969). 
The head is small and almost spherical. It is joined to the thorax by a narrow 
membranous connection. A large pair of compound eyes occupies the lateral surface of 
the head. This mosquito has a pair of long, filamentous and segmented antennae. The 
male mosquito's antennae are conspicuous and plumose while the female are pilose. 
The proboscis is long and slender, and projects downwards and forwards from the lower 
front margin of the head. The proboscis of Ae. aegypti consists of a long, "u"-shaped, 
fleshy, sheath-like structure, namely labium, enclosing a group of six stylets and is 
adapted for piercing and sucking. The labium encloses paired maxillae, mandibles, an 
epipharynx and a hypopharynx. The roof of the proboscis is formed by the labrum, a 
shelf like projection of the head. The hypopharynx carries a salivary duct, through 
which an anticoagulant is projected from the floor of the oral cavity, and delivered into 
the hosts tissues (Suzanne, 2004). 
Culicidae mosquitos' families have three pairs of long legs and two wings attached to 
the thorax. The wings are covered with dark scale. The sides of the thorax of Culicidae 
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may be covered with scale bristles and bear several groups of hair or bristles, but Aedes 
species do not have spiracular bristles in front of the mesothoracic spiracles. Instead, 
Aedes species have post-spiracular bristles (a group of bristles immediately behind the 
mesothoracic spiracle) (Suzanne, 2004). The hind legs have pale scales on the basal 
three-quarters of the femur, with dark scales covering dorsally on the apical two-thirds 
and ventrally on the apical third. The tibia is dark but tarsi with pale basal bands on 1- 4 
and 5 are all pale (Russell, 1996). 
The abdomen is elongated and nearly cylindrical. It consists of ten segments, of which 
only eight are readily available as the ninth and tenth segments are greatly modified for 
sexual functions. Gonopore, the external opening of the reproductive organs, is situated 
on the posterior portion of abdomen. They have a pointed tip to the abdomen with the 
paired cerci Gointed appendage at the tip of the abdomen in insects) protruding. The 
female Aedes mosquitoes' abdomens are tapered apically, with the eighth segment 
withdrawn into the seventh (Suzanne, 2004). 
Ae. aegypti is highly anthropophilic, although it may feed on other available warm 
blooded animals. Being a diurnal species, females have two periods of biting activity, 
one in the morning for several hours after daybreak and the other in the afternoon for 
several hours before dark (WHO, 1999). Ae. aegypti may feed on more than one person 
when there is an interruption during feeding (WHO, 1999). The adult male (and 
occasionally the females) feed on nectar and other plant juices (Suzanne, 2004). Ae. 
aegypti prefers to rest in dark, humid, secluded places inside houses or buildings. Less 
often, it can be found outdoors in vegetation or other protected sites (WHO, 1999). 
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